We are live on ! Find out more
D.E. Shaw & Co

D.E. Shaw & Co Portfolio holdings

AUM $166B
1-Year Est. Return 43.98%
 

D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.

This Fund
S&P 500
This Quarter Est. Return
+6.67%
1 Year Est. Return
+43.98%
3 Year Est. Return
+138.44%
5 Year Est. Return
+164.23%
10 Year Est. Return
+713.02%
AUM
$76.7B
AUM Growth
+$3.2B
Cap. Flow
-$965M
Cap. Flow %
-1.26%
Top 10 Hldgs %
9.81%
Holding
4,066
New
622
Increased
1,512
Reduced
1,263
Closed
399

Sector Composition

Rank Sector Weight
1 Technology 14.14%
2 Consumer Discretionary 12.42%
3 Healthcare 10.3%
4 Financials 9.14%
5 Industrials 6.71%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ICUI icon
2576
CALL
ICU Medical
ICUI
$4.03B
$1.15M ﹤0.01%
3,900
-200
-5% -$54.7K
DVAX
2577
CALL
DELISTED
Dynavax Technologies
DVAX
$1.14M ﹤0.01%
+75,000
New +$1.3M
BZUN
2578
Baozun
BZUN
$164M
$1.14M ﹤0.01%
+20,904
New +$1.11M
NHTC icon
2579
Natural Health Trends
NHTC
$16.2M
$1.14M ﹤0.01%
45,704
-6,007
-12% -$126K
WH icon
2580
CALL
Wyndham Hotels & Resorts
WH
$5.58B
$1.14M ﹤0.01%
+19,400
New +$1.19M
RCKT icon
2581
Rocket Pharmaceuticals
RCKT
$355M
$1.13M ﹤0.01%
57,750
-81,450
-59% -$1.54M
SFS
2582
DELISTED
Smart & Final Stores, Inc.
SFS
$1.13M ﹤0.01%
204,407
+67,675
+49% +$342K
ALNY icon
2583
PUT
Alnylam Pharmaceuticals
ALNY
$37.2B
$1.13M ﹤0.01%
11,500
-4,500
-28% -$446K
HUBB icon
2584
PUT
Hubbell
HUBB
$26.3B
$1.13M ﹤0.01%
+10,700
New +$1.18M
WUBA
2585
CALL
DELISTED
58.com Inc
WUBA
$1.13M ﹤0.01%
16,300
DPLO
2586
DELISTED
DIPLOMAT PHARMACY, INC.
DPLO
$1.13M ﹤0.01%
44,223
-215,160
-83% -$5.02M
KEM
2587
PUT
DELISTED
KEMET Corporation
KEM
$1.13M ﹤0.01%
46,800
+25,500
+120% +$519K
EDR
2588
DELISTED
Education Realty Trust Inc
EDR
$1.12M ﹤0.01%
27,107
-221,619
-89% -$7.9M
ARE icon
2589
PUT
Alexandria Real Estate Equities
ARE
$8.95B
$1.12M ﹤0.01%
8,900
PAAS icon
2590
Pan American Silver
PAAS
$18.6B
$1.12M ﹤0.01%
62,747
+22,953
+58% +$396K
GLRE icon
2591
Greenlight Captial
GLRE
$570M
$1.12M ﹤0.01%
78,932
-11,485
-13% -$175K
DLR icon
2592
CALL
Digital Realty Trust
DLR
$72.4B
$1.12M ﹤0.01%
10,000
NPKI
2593
NPK International
NPKI
$1.19B
$1.11M ﹤0.01%
102,779
-19,979
-16% -$203K
MHK icon
2594
CALL
Mohawk Industries
MHK
$7.05B
$1.11M ﹤0.01%
+5,200
New +$1.14M
NEU icon
2595
NewMarket
NEU
$7.14B
$1.11M ﹤0.01%
+2,753
New +$1.08M
SSD icon
2596
Simpson Manufacturing
SSD
$7.95B
$1.11M ﹤0.01%
17,877
-456
-2% -$27.7K
TROW icon
2597
T. Rowe Price
TROW
$25.5B
$1.11M ﹤0.01%
9,571
-24,001
-71% -$2.79M
NBIS
2598
CALL
Nebius Group N.V.
NBIS
$47.7B
$1.11M ﹤0.01%
+30,800
New +$1.07M
CAI
2599
DELISTED
CAI International, Inc.
CAI
$1.11M ﹤0.01%
47,604
-129,287
-73% -$3M
FBR
2600
DELISTED
Fibria Celulose Sa
FBR
$1.1M ﹤0.01%
59,459
-29,371
-33% -$565K

Similar funds

D.E. Shaw & Co's Q2 2018 Portfolio in Review

As of Q2 2018, D.E. Shaw & Co held 4,066 positions worth $76.7B, up 4.4% from $73.5B the previous quarter. Its ten largest holdings account for 9.8% of the portfolio.

D.E. Shaw & Co's Q2 2018 filing shows 622 new, 1,512 increased, 1,263 reduced and 399 closed positions. Its largest new stake was Evergy: 4,161,679 shares worth $234M. The largest sale was Time Warner Inc, an estimated $648M.

By sector, the portfolio is most concentrated in Technology at 14% of assets, down from 15% a quarter earlier, followed by Consumer Discretionary and Healthcare.

  • D.E. Shaw & Co's largest Q2 2018 buy was Evergy: 4,161,679 shares worth $234M.
  • D.E. Shaw & Co added most to Amazon in Q2 2018, an estimated $696M increase.
  • D.E. Shaw & Co's biggest Q2 2018 reduction was Merck, cutting an estimated $453M.
  • D.E. Shaw & Co fully exited Time Warner Inc in Q2 2018, selling an estimated $648M.
  • D.E. Shaw & Co's ten largest holdings make up 9.8% of its $76.7B portfolio in Q2 2018.
  • D.E. Shaw & Co opened 622 new positions and closed 399 in Q2 2018.
  • D.E. Shaw & Co's portfolio value rose 4.4% quarter-over-quarter to $76.7B.

Based on D.E. Shaw & Co's 13F filing for Q2 2018, filed 14 Aug 2018.